Rebetol

Indicated For

Hepatitis C

About This Medication

# Schering-Plough Patient Assistance Program Patient Guide: How to Get Rebetol (ribavirin) at Low or No Cost Rebetol (ribavirin) is an antiviral medication used to treat chronic hepatitis C virus (HCV) infection, often in combination with interferon. The **Schering-Plough Patient Assistance Program** helps eligible uninsured patients get **Rebetol** at low or no cost if they meet income and other requirements. ## About Rebetol (ribavirin) **Rebetol (ribavirin)** is a prescription oral capsule taken to fight hepatitis C, a viral infection that damages the liver over time. It works by stopping the virus from spreading in the body. Doctors usually prescribe it with peginterferon alfa (like Pegasys or Intron) for better results. Common side effects include fatigue, anemia, headache, and nausea—talk to your doctor if these bother you. It's not a cure but can help clear the virus in some patients. Always follow your healthcare provider's instructions, as dosing depends on your weight and genotype of the virus. This guide explains the **Schering-Plough Patient Assistance Program** (originally called Commitment to Care for hepatitis drugs like Rebetol). Note: Schering-Plough merged into Merck, but this program uses the original contact details. Programs evolve, so verify current status by calling. ## Who Qualifies? To qualify, you must: - Live in the US (no citizenship required). - Have no prescription insurance and not be eligible for government programs like Medicaid or Medicare Part D. - Meet income guidelines (not publicly disclosed; call for prescreening). - Have a valid prescription from a US-licensed doctor. The program targets low-income patients struggling to afford **Rebetol**. Historically, eligibility was around 200-250% of the Federal Poverty Level (FPL), helping singles up to ~$25,000 and couples up to ~$33,000 annually (adjusted for inflation and location). Exact current thresholds require a phone prescreen. ## Income Eligibility Breakdown Income guidelines are **not disclosed online**—you must call (800) 521-7157 for prescreening. They assess household income, size, and residency. Here's a general table based on historical data (2005-era, for illustration; call for 2026 updates): | Household Size | Approx. Max Income (200% FPL, 2005) | Approx. Max Income (250% FPL, 2005) | Notes | |---------------|-------------------------------------|-------------------------------------|-------| | 1 (Individual) | $18,850 | $23,500 | Adjusted yearly for FPL | | 2 (Couple) | $25,350 | $33,000 | Includes all household income | | 3 | $31,850 | ~$41,000 | Call for exact family thresholds | | 4 | $38,350 | ~$49,000 | Proof required (tax returns, pay stubs) | **Important**: These are estimates. Percentages like 200-250% FPL were expanded historically. Provide proof of income during application. No assets test mentioned, but they verify via credit report or documents without affecting your score. ## Insurance Requirements **Strict rules apply**: - **No prescription insurance** allowed (private or employer plans covering **Rebetol**). - **Ineligible for government programs** (Medicaid, Medicare Part D, VA, etc.). - If you have Medicare, you may qualify only if you've enrolled in Part D, can't find affordable coverage, applied for low-income subsidy and were denied, and drug costs exceed 3% of household income (per historical policy). Check your status: Uninsured patients get priority. Underinsured? Explore other options first. ## Step-by-Step Application Process Applications are **phone-based only**—no online form or URL. 1. **Prescreen for Eligibility**: Call **(800) 521-7157**. Provide basics: income, household size, insurance status, residency. They'll guide if you qualify. 2. **Gather Documents**: - **Proof of income**: Recent tax return (1040), pay stubs (1 month), Social Security/pension letter, unemployment statement, or employer letter. - **Insurance information**: Proof of no coverage (e.g., denial letter) or Medicare Part D low-income subsidy denial. - Valid **Rebetol** prescription from your doctor. 3. **Complete Application**: Follow phone instructions. Your doctor may need to sign sections confirming diagnosis and prescription. 4. **Submit**: Mail or fax as directed (originals preferred; no fax for some programs). Include all docs. 5. **Wait for Approval**: 7-10 business days typical. Doctor involvement is key—ask them to help certify your need. ## Timeline and Delivery - **Processing**: 7-10 business days after full submission. - **Urgent needs**: Call during prescreen for expedited help. - **Delivery**: Shipped free **directly to your home** (not doctor's office). - **Supply duration**: Often 90+ days; reauthorization needed for refills. Track by calling the program. If delayed, resubmit missing docs. ## Alternatives if Denied or Ineligible - **Merck Patient Assistance Program** (current Schering-Plough successor): Call 800-727-5400 or visit merckhelps.com. Covers similar drugs; up to 400-500% FPL, some Medicare ok. - **RxHope** or **NeedyMeds**: Search for **Rebetol** alternatives. - **Generic ribavirin**: Cheaper via discount cards (GoodRx) or state programs if insured. - **Patient Access Network (PAN) Foundation** or **HealthWell Foundation**: Grants for hep C copays. - **Newer treatments**: Ask doctor about direct-acting antivirals (e.g., sofosbuvir) with their PAPs—often cure hep C faster. - **No biosimilars** for Rebetol listed. ## Reauthorization and Refills **Reauthorization required** yearly or per supply cycle. Resubmit updated income/insurance proof. Track refill dates to avoid gaps. ## Disclaimer This guide is for informational purposes based on provided program details and historical data as of 2026. **Eligibility, rules, and contacts change**—always call **(800) 521-7157** to confirm. Not medical/financial advice. Consult your doctor for treatment options. Program not guaranteed; denials possible. Schering-Plough is now Merck—verify via MerckHelps.com if needed. Word count: 1028.

Program information last verified: March 30, 2026